Effects of bleomycin on human and experimental squamous carcinoma.
D000818:Animals; D000903:Antibiotics, Antineoplastic / Q000627:therapeutic use*; D001706:Biopsy; D001761:Bleomycin / Q000494:pharmacology / Q000627:therapeutic use; D002294:Carcinoma, Squamous Cell / Q000188:drug therapy* / Q000473:pathology; D046508:Culture Techniques; D003896:Desmosomes; D004428:Ear Neoplasms / Q000188:drug therapy; D004825:Epiglottis; D006003:Glycogen; D006801:Humans; D007633:Keratins; D007822:Laryngeal Neoplasms / Q000188:drug therapy; D008441:Maxillary Neoplasms / Q000188:drug therapy; D051379:Mice; D008854:Microscopy, Electron; D009062:Mouth Neoplasms / Q000188:drug therapy; D009374:Neoplasms, Experimental / Q000188:drug therapy; D010157:Palatal Neoplasms / Q000188:drug therapy; D014062:Tongue Neoplasms / Q000188:drug therapy; D014067:Tonsillar Neoplasms / Q000188:drug therapy
D000903:Antibiotics, Antineoplastic; D001761:Bleomycin; D007633:Keratins; D006003:Glycogen